SUNOSI® (Solriamfetol) Pregnancy Registry
Part of paid clinical trials in Morrisville, North Carolina.
- Sponsor
- Axsome Therapeutics, Inc.
- Study ID
- NCT06413420
- Status
- Recruiting
Conditions
- Narcolepsy
- Obstructive Sleep Apnea
- Pregnant Women and Their Offspring
Eligibility Criteria
- Sex
- FEMALE
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Sunosi (solriamfetol) — DRUGExposure to at least 1 dose of solriamfetol at any time during pregnancy.
- Other prescription wake-promoting medications or stimulants — DRUGExposure to at least 1 dose of a prescription wake-promoting medication or stimulant at any time during pregnancy.
- No treatment — OTHERNo treatment
Study Details
The SUNOSI (solriamfetol) Pregnancy Registry is a prospective, multi-country, observational study to evaluate the safety of solriamfetol exposure during pregnancy in women with a diagnosis of narcolepsy or obstructive sleep apnea (OSA).
Key Dates
- Start date
- Jul 31, 2019
- Status verified
- May 2024
- Primary completion
- Sep 30, 2029
- Completion
- Sep 30, 2029
Study Design
- Enrollment
- 1,731 participants (estimated)
Arms
- Arm: Cohort 1: Solriamfetol-exposed participants with narcolepsy or OSAPregnant women with a diagnosis of narcolepsy or OSA
- Arm: Cohort 2: Unexposed participants with narcolepsy or OSAPregnant women with a diagnosis of narcolepsy or OSA
- Arm: Cohort 3: Other-exposed participants with narcolepsy or OSAPregnant women with a diagnosis of narcolepsy or OSA
- Arm: Cohort 4: Solriamfetol-exposed participants without narcolepsy or OSAPregnant women without a diagnosis of narcolepsy or OSA
- Arm: Cohort 5: Other-exposed participants without narcolepsy or OSAPregnant women without a diagnosis of narcolepsy or OSA
Primary Outcome Measure
Long-term Safety [ Time Frame: Baseline up to 12 months after pregnancy outcome ]
Central Contacts
- Study Director1-877-283-6220
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Evidera, a PPD business unit | Morrisville | North Carolina | 27560 | - |
| PPD, Inc. | Wilmington | North Carolina | 28401 | - |
Find similar trials in Morrisville, NC
Related Studies
- Pediatric Post-Approval RegistryRecruiting · Inspire Medical Systems, Inc. · Aurora, Colorado
- WAKIX® (Pitolisant) Pregnancy RegistryRecruiting · Harmony Biosciences Management, Inc. · Morrisville, North Carolina
- Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure TherapyPHASE3 · Recruiting · Amgen · Northridge, California
- Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) TherapyPHASE3 · Recruiting · Amgen · Northridge, California